Baillie Gifford & Co’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-460
Closed -$16.2K 390
2023
Q1
$16.2K Buy
460
+55
+14% +$1.99K ﹤0.01% 357
2022
Q4
$13.8K Hold
405
﹤0.01% 385
2022
Q3
$13K Hold
405
﹤0.01% 384
2022
Q2
$14K Buy
405
+5
+1% +$210 ﹤0.01% 376
2022
Q1
$23K Hold
400
﹤0.01% 353
2021
Q4
$30K Buy
+400
New +$25.6K ﹤0.01% 330
2021
Q1
Sell
-861
Closed -$33K 456
2020
Q4
$33K Buy
+861
New +$25K ﹤0.01% 288

Other funds holding MXL

Baillie Gifford & Co's MXL Position: Q2 2023 in Review

Baillie Gifford & Co sold out of MaxLinear (MXL) in Q2 2023, closing a stake of 460 shares — an estimated $16.2K sold.

Baillie Gifford & Co first reported a position in MXL in Q4 2020 and held it in 7 quarters. The position peaked at $33K in Q4 2020. 251 funds tracked by Wall St. Rank hold MXL as of Q2 2023.

  • Baillie Gifford & Co reported no remaining MaxLinear position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 460 MaxLinear shares in Q2 2023, an estimated $16.2K.
  • Baillie Gifford & Co first reported a position in MaxLinear in Q4 2020 and held it in 7 quarters.
  • Baillie Gifford & Co's MaxLinear position peaked at $33K in Q4 2020.
  • 251 funds tracked by Wall St. Rank held MaxLinear as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.